NCT06189976

Brief Summary

Despite Transcatheter aortic valve implantation (TAVI) evolution regarding techniques, equipment and experience, the need for permanent pacemaker implantation (PPI) post-TAVI remains an important drawback. The electrophysiology testing to stratify the risk or necessity of PPI post-TAVI is endorsed by the up-to-date guidelines and consensus documents and it is a valuable cut-off based method. Part of the answer is maybe hidden in the easy and applicable testing of the atrioventricular conduction system through rapid atrial pacing (RAP) with a common temporary pacemaker lead. This trial is designed to investigate the role and value of RAP after TAVI as a predictor of the necessity of new PPI.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
2 countries

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 12, 2024

Status Verified

December 1, 2024

Enrollment Period

1.2 years

First QC Date

December 17, 2023

Last Update Submit

December 9, 2024

Conditions

Keywords

TAVRTAVIRapid atrial pacingAortic stenosis

Outcome Measures

Primary Outcomes (1)

  • Permanent pacemaker implantation rates

    Rates of permanent pacemaker implantation after TAVI

    30 days

Secondary Outcomes (5)

  • Mortality rates

    30 days

  • Mortality rates

    6 months

  • Permanent pacemaker implantation rates

    6 months

  • Mortality rates

    12 months

  • Permanent pacemaker implantation rates

    12 months

Study Arms (1)

Rapid atrial pacing

OTHER

Diagnostic test group (single group)

Diagnostic Test: Rapid atrial pacing

Interventions

Rapid atrial pacingDIAGNOSTIC_TEST

Rapid atrial pacing after TAVI

Rapid atrial pacing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ≥18 years old.
  • Patient understands the purpose, the potential risks as well as benefits of the trial and is willing to participate in all parts of the follow-up.
  • Patient has given written consent to participate in the trial.
  • Patients undergoing TAVI as a treatment of severe aortic stenosis (AS).
  • Patient in sinus rhythm.
  • Patients planned for TAVI with utilization of temporary pacemaker electrode placement.

You may not qualify if:

  • Ongoing infection, including active endocarditis.
  • Implanted permanent pacemaker and/or implantable cardioverter/defibrillator.
  • Patients developing persistent second or third degree atrioventricular block (AV) after TAVI.
  • Underlying rhythm other than sinus based on the surface ECG leads monitoring after TAVI.
  • Patients with second or third degree AV block identifyied on the screening pre-TAVI ECG.
  • Enrolment in another study that competes or interferes with this study.
  • Subject will not be able to comply with the follow-up requirements according to investigators' opinion.
  • Pregnant or breast-feeding females or females who intend to become pregnant during the time of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU Saint-Pierre

Brussels, 1000, Belgium

RECRUITING

Hippocration Hospital

Athens, Attica, 11527, Greece

RECRUITING

Related Publications (4)

  • Knecht S, Schaer B, Reichlin T, Spies F, Madaffari A, Vischer A, Fahrni G, Jeger R, Kaiser C, Osswald S, Sticherling C, Kuhne M. Electrophysiology Testing to Stratify Patients With Left Bundle Branch Block After Transcatheter Aortic Valve Implantation. J Am Heart Assoc. 2020 Mar 3;9(5):e014446. doi: 10.1161/JAHA.119.014446. Epub 2020 Feb 22.

  • Krishnaswamy A, Sammour Y, Mangieri A, Kadri A, Karrthik A, Banerjee K, Kaur M, Giannini F, Pagliaro B, Ancona M, Pagnesi M, Laricchia A, Weisz G, Lyden M, Bazarbashi N, Gad M, Ahuja K, Mick S, Svensson L, Puri R, Reed G, Rickard J, Colombo A, Kapadia S, Latib A. The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker Implantation. JACC Cardiovasc Interv. 2020 May 11;13(9):1046-1054. doi: 10.1016/j.jcin.2020.01.215. Epub 2020 Apr 15.

  • Tan BE, Hashem A, Boppana LKT, Mohamed MS, Abbas SF, Faisaluddin M, Thakkar S, Ahmed AK, Hall C, Abtahian F, Rao M, Bhatt DL, Depta JP. Utility of rapid atrial pacing before and after TAVR with balloon-expandable valve in predicting permanent pacemaker implantation. Catheter Cardiovasc Interv. 2023 Nov;102(5):919-928. doi: 10.1002/ccd.30817. Epub 2023 Sep 12.

  • Koliastasis L, Doundoulakis I, Tsiachris D, Pannone L, Skalidis I, de Hemptinne Q, Xaplanteris P, Toutouzas K, de Asmundis C. Rapid Atrial Pacing After TAVI for Pacemaker Prediction. Rev Cardiovasc Med. 2025 Aug 15;26(8):39074. doi: 10.31083/RCM39074. eCollection 2025 Aug.

MeSH Terms

Conditions

Aortic Valve DiseaseAortic Valve Stenosis

Condition Hierarchy (Ancestors)

Heart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Study Officials

  • Leonidas Koliastasis

    National and Kapodistrian University of Athens

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Leonidas Koliastasis, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Interventional Cardiology Fellow

Study Record Dates

First Submitted

December 17, 2023

First Posted

January 5, 2024

Study Start

March 1, 2024

Primary Completion

April 30, 2025

Study Completion

December 31, 2025

Last Updated

December 12, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations